
DBV Technologies has appointed Dr Hugh Sampson as its chief scientific officer. The French biotech company is developing the Viaskin peanut allergy treatment patch. Dr …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

